Ikazia Hospital, Rotterdam
7
3
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
High Flow Nasal Oxygen for Exacerbation COPD
Role: collaborator
Appropriate Medication Use in Dutch Terminal Care
Role: collaborator
Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction
Role: collaborator
Implementation of Online Advance Care Planning Tool for (Hemato-)Oncological Patients Within the Cancer Network Concord
Role: collaborator
The ICU DElirium in Clinical PracTice Implementation Evaluation Study Screening and Treatment
Role: collaborator
Cost-Effectiveness in Bladder Cancer
Role: collaborator
Mechanical Bowel Preparation for Elective Colorectal Surgery
Role: lead
All 7 trials loaded